Developmental and epileptic encephalopathies after negative or inconclusive genetic testing: what is next?

  title={Developmental and epileptic encephalopathies after negative or inconclusive genetic testing: what is next?},
  author={{\'A}ngel Aledo-Serrano and Roc{\'i}o S{\'a}nchez-Alcudia and Rafael Toledano and Irene Garc{\'i}a-Morales and {\'A}lvaro Beltr{\'a}n-Corbellini and Isabel del Pino and Antonio Gil-Nagel},
  journal={Journal of Translational Genetics and Genomics},
The redefinition of classical electroclinical syndromes and the emergence of neurogenetics has led to a revolution in the field of developmental and epileptic encephalopathies (DEEs). In this context, advances in genetic techniques are leading to the final diagnosis of a large proportion of patients with DEE. However, up to 50% of patients with DEE remain undiagnosed. For patients with uncertain genetic etiology, there is a pressing need for the implementation of new targeted treatments and… 

Figures from this paper

The Genetic Diagnosis of Ultrarare DEEs: An Ongoing Challenge

A dynamic diagnostic procedure used to investigate 17 patients with DEE or EE with previous negative or inconclusive genetic testing by whole-exome sequencing (WES), leading to a definite diagnosis in about 59% of participants, emphasizes the role of recessive and somatic variants, new genetic mechanisms, and the complexity of genotype–phenotype associations.

Epilepsy Genetics and Precision Medicine in Adults: A New Landscape for Developmental and Epileptic Encephalopathies

This review aims to provide an updated perspective of epilepsy genetics and precision medicine in adult patients, with special focus on developmental and epileptic encephalopathies (DEEs), covering

The Charlotte Project: Recommendations for patient-reported outcomes and clinical parameters in Dravet syndrome through a qualitative and Delphi consensus study

The results showed consensus regarding the regular evaluation of several clinical parameters related to neurodevelopment, attention, behavior, other comorbidities, and sudden unexpected death in epilepsy (SUDEP) related to the general evaluation of QoL.



Advances in genetic testing and optimization of clinical management in children and adults with epilepsy

This review will explore the most recent advancements in genetic testing and provide up-to-date approaches for the choice of the correct test in patients with epilepsy.

Epilepsy Syndromes in the First Year of Life and Usefulness of Genetic Testing for Precision Therapy

The aim of this study was to review the clinical and genetic heterogeneity associated with epilepsy syndromes starting in the first year of life including self-limited familial neonatal, neonatal-infantile or infantile epilepsies, genetic epilepsy with febrile seizures plus spectrum, and myoclonic epilepsy in infancy.

Recent advances in epilepsy genomics and genetic testing

This review discusses the major advances in epilepsy genomics that have surfaced in recent years and aims to build a better understanding of pathogenesis and genetic testing options in DEE.

Targeted re-sequencing for early diagnosis of genetic causes of childhood epilepsy: the Italian experience from the ‘beyond epilepsy’ project

The findings support the efficacy of target re-sequencing in the identification of the genetic causes of childhood epilepsy and suggest that this technique might prove successful in the early detection of CLN2 as well as other neurodevelopmental conditions.

Epilepsy and developmental disorders: Next generation sequencing in the clinic.

  • J. SymondsA. Mctague
  • Medicine, Psychology
    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
  • 2019

The genetic landscape of intellectual disability and epilepsy in adults and the elderly: a systematic genetic work-up of 150 individuals

  • Pia ZacherT. Mayer J. Lemke
  • Medicine, Biology
    Genetics in medicine : official journal of the American College of Medical Genetics
  • 2021
Panel/exome sequencing displayed the highest yield and should be considered as first-tier diagnostics in NDDE and knowledge of the course of elderly individuals will ultimately help in counseling newly diagnosed individuals with NDDE.

De novo mutations in epileptic encephalopathies

  • Biology, Medicine
  • 2013
A screen for de novo mutations in patients with two classical epileptic encephalopathies, a heterogeneous group of severe epilepsy disorders characterized by early onset of seizures with cognitive and behavioural features associated with ongoing epileptic activity is reported.

From Genetic Testing to Precision Medicine in Epilepsy

The most recent advances in genetic testing are summarized and up-to-date approaches for the choice of the correct test for some epileptic disorders and tailored treatments that are already applicable in some monogenic epilepsies are provided.

Precision therapy in the genetic epilepsies of childhood

The current and potential use of precision medicine in the genetic epilepsies of childhood is discussed and how optimal control and a reduction in the rate of refractory seizures using targeted therapy could be developed and assessed are discussed.